Loading
Diabetes and Associated Disorders · Journal article
The Journal of Medical Sciences · August 7, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review that presents established mechanistic knowledge linking gut dysbiosis to both type 1 and type 2 diabetes, describing how microbial composition affects metabolic and immune regulation. It does not report new primary evidence, clinical trial results, or systematic meta-analysis, and therefore cannot quantify the magnitude or clinical significance of microbiota manipulation on diabetes outcomes.
Journal article. General human population; discussion of individuals with type 1 and type 2 diabetes mellitus.
Both T1DM and T2DM have been linked to dysbiosis, which influences onset, progression, and therapeutic outcomes Firmicutes are key SCFA producers, particularly butyrate, critical for gut barrier function and anti-inflammatory effects Bacteroidetes break down complex carbohydrates and polysaccharides, contributing to energy balance and immune modulation
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review provides conceptual framework for understanding microbiota's role in diabetes pathogenesis and suggests potential therapeutic targets (diet, probiotics, medications), but clinicians require systematic evidence synthesis or clinical trials to guide specific interventions.
This is a narrative review article presenting mechanistic concepts and existing knowledge about microbiota-diabetes relationships, without reporting new primary data, clinical trials, or systematic evidence synthesis.
This review provides conceptual framework for understanding microbiota's role in diabetes pathogenesis and suggests potential therapeutic targets (diet, probiotics, medications), but clinicians require systematic evidence synthesis or clinical trials to guide specific interventions.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Commentaryfibers.SCFAs serve multiple roles, including maintaining gut barrier integrity, regulating immune function, and providing energy to colonocytes.In a healthy gut, a balance between the predominant bacterial phyla, especially Firmicutes and Bacteroidetes, is essential for optimal metabolic and immune regulation.Firmicutes are key producers of butyrate, an SCFA critical for maintaining gut barrier function and possessing anti-inflammatory properties.Bacteroidetes, on the other hand, are involved in breaking down complex carbohydrates and polysaccharides, contributing to energy balance and immune modulation.The gut microbiota also plays an essential role in interacting with the immune system, primarily through the gut-associated lymphoid tissue (GALT).The GALT forms part of the mucosal immune system and helps maintain a delicate balance IntroductIonThe gut microbiota, an intricate ecosystem comprising trillions of microorganisms, has emerged as a significant player in various metabolic and immune functions in the human body.Recent advancements in microbiome research have highlighted the essential role that the gut microbiota plays in maintaining overall health and its implications in metabolic disorders such as obesity, diabetes mellitus, and cardiovascular diseases.Both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) have been linked to imbalances in the gut microbiota, also known as dysbiosis, which can influence the onset, progression, and therapeutic outcomes of these diseases.1 Diabetes mellitus, a chronic condition characterized by hyperglycemia, is caused either by the body's inability to produce insulin (T1DM) or by insulin resistance combined with an inadequate compensatory insulin secretion (T2DM).The growing prevalence of diabetes has placed a significant burden on healthcare systems worldwide.2 Exploring the gut microbiota's role in diabetes provides new insights into possible preventive and therapeutic strategies.This review aims to elaborate on the relationship between gut microbiota and diabetes, focusing on how dysbiosis contributes to disease development and progression, and how manipulating the microbiota through diet, probiotics, or medications can offer novel therapeutic avenues. Gut MIcrobIota I n HealtH a n d dIsease Composition and Function of Gut MicrobiotaThe human gastrointestinal (GI) tract harbors a diverse community of microorganisms, including bacteria, archaea, fungi, viruses, and protozoa.Bacteria form the bulk of this community and can be grouped into several phyla, of which Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria dominate.These microorganisms play a pivotal role in various physiological processes, including digestion, vitamin synthesis, and immune response modulation.Importantly, gut bacteria produce short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, through the fermentation of dietary
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.